Cargando…
Incidence of metachronous visible lesions in patients referred for radiofrequency ablation (RFA) therapy for early Barrett's neoplasia: a single-centre experience
OBJECTIVE: Evaluate the incidence of metachronous visible lesions (VLs) in patients referred for radiofrequency ablation (RFA) for early Barrett's neoplasia. DESIGN: This study was conducted as part of the service evaluation audit. SETTING: Tertiary referral centre. PATIENTS: All patients with...
Autores principales: | Ortiz-Fernández-Sordo, J, Sami, S, Mansilla-Vivar, R, De Caestecker, J, Cole, A, Ragunath, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717434/ https://www.ncbi.nlm.nih.gov/pubmed/26834956 http://dx.doi.org/10.1136/flgastro-2015-100561 |
Ejemplares similares
-
Monitoring the premalignant potential of Barrett's oesophagus'
por: Graham, David, et al.
Publicado: (2016) -
Guide to managing persistent upper gastrointestinal symptoms during and after treatment for cancer
por: Andreyev, H Jervoise N, et al.
Publicado: (2017) -
Recent advances in the detection and management of early gastric cancer and its precursors
por: Waddingham, William, et al.
Publicado: (2020) -
Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry
por: Haidry, R J, et al.
Publicado: (2015) -
Developing patient-orientated Barrett’s oesophagus services: the role of dedicated services
por: Ratcliffe, Elizabeth, et al.
Publicado: (2022)